Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifeward ( (LFWD) ) has shared an announcement.
Lifeward Ltd. reported that 7,252,783 ordinary shares, representing about 39.7% of its outstanding shares as of January 20, 2026, were present or voted at its March 12, 2026 extraordinary general meeting, establishing quorum and enabling shareholders to approve all proposals on the agenda. Investors backed the issuance of new shares tied to the Oratech Pharma acquisition and related financing instruments, the contingent election and compensation framework of external directors, an increase in shares under the 2025 incentive plan, an equity grant for CEO Mark Grant, and the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as independent auditor through 2026, decisions that collectively reinforce the company’s M&A strategy, governance structure, and equity-based compensation capacity.
The approvals secure shareholder support for the Oratech deal financing and governance changes.
They also expand equity incentives and confirm the external auditor, underpinning growth plans.
The most recent analyst rating on (LFWD) stock is a Hold with a $0.65 price target. To see the full list of analyst forecasts on Lifeward stock, see the LFWD Stock Forecast page.
Spark’s Take on LFWD Stock
According to Spark, TipRanks’ AI Analyst, LFWD is a Neutral.
The score is held down primarily by very weak profitability and heavy cash burn despite solid revenue growth and low debt. Technicals are neutral with only modest improving momentum, and valuation is constrained by ongoing losses (negative P/E). Offsetting factors include operational improvements and guidance reaffirmation from the earnings call plus liquidity/strategic support from the Oramed-related financing and transactions, albeit with dilution and control-risk tradeoffs.
To see Spark’s full report on LFWD stock, click here.
More about Lifeward
Lifeward Ltd. is a publicly traded company that issues ordinary shares and operates under Israeli corporate governance rules, including the appointment of external directors as defined by Israel’s Companies Law. The company utilizes equity-based incentive compensation plans and relies on a global audit firm, reflecting a growth-oriented, capital-markets-focused corporate structure.
Average Trading Volume: 27,349
Technical Sentiment Signal: Sell
Current Market Cap: $10.15M
Learn more about LFWD stock on TipRanks’ Stock Analysis page.